Clinical trial
CASPA (CArdiac Sarcoidosis in PApworth): Improving the Diagnosis of Cardiac Disease in Patients With Pulmonary Sarcoidosis
NCT03599414 is registered in ClinicalTrials.gov with Papworth Hospital NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CASPA (CArdiac Sarcoidosis in PApworth): Improving the Diagnosis of Cardiac Disease in Patients With Pulmonary Sarcoidosis
- Lead sponsor
- Papworth Hospital NHS Foundation Trust
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 29, 2017
- Completion date
- March 8, 2023
- Enrollment
- 104 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac sarcoidosis, interstitial lung disease, pulmonary sarcoidosis